# A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.

> **NCT02976987** · PHASE2 · COMPLETED · sponsor: **Brugmann University Hospital** · enrollment: 36 (actual)

## Conditions studied

- High Grade Cervical Epithelial Neoplasia (CIN2+)

## Interventions

- **DRUG:** Cidofovir

## Key facts

- **NCT ID:** NCT02976987
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976987, "A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02976987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*